Viatris (VTRS) Interest Coverage Ratio Growth (1y) (2020 - 2026)
Viatris (VTRS) Interest Coverage Ratio Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -83.16% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 128.45% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -97.39% |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | -8.29% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -99.73% |
| Mar 31, 2026 | 97.17% |
| Dec 31, 2025 | -7.71% |
| Sep 30, 2025 | -3.64% |
| Jun 30, 2025 | 111.47% |
| Mar 31, 2025 | -2,128.02% |
| Dec 31, 2024 | 53.63% |
| Sep 30, 2024 | -51.40% |
| Jun 30, 2024 | -164.04% |
| Mar 31, 2024 | -44.88% |
| Dec 31, 2023 | -216.00% |
| Sep 30, 2023 | 1,067.80% |
| Jun 30, 2023 | 882.37% |
| Mar 31, 2023 | -36.71% |
| Dec 31, 2022 | -94.95% |
| Sep 30, 2022 | 71.00% |
| Jun 30, 2022 | 1,334.90% |
| Mar 31, 2022 | 378.52% |
| Dec 31, 2021 | 91.42% |
| Sep 30, 2021 | -94.92% |